199 related articles for article (PubMed ID: 33089424)
21. Inhibition of brain mitochondrial monoamine oxidases by the endogenous compound 5-hydroxyoxindole.
Crumeyrolle-Arias M; Tournaire MC; Cane A; Launay JM; Barritault D; Medvedev A
Biochem Pharmacol; 2004 Mar; 67(5):977-9. PubMed ID: 15104251
[TBL] [Abstract][Full Text] [Related]
22. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of brain mitochondrial respiration by dopamine: involvement of H(2)O(2) and hydroxyl radicals but not glutathione-protein-mixed disulfides.
Gluck M; Ehrhart J; Jayatilleke E; Zeevalk GD
J Neurochem; 2002 Jul; 82(1):66-74. PubMed ID: 12091466
[TBL] [Abstract][Full Text] [Related]
24. (±)-
Ismaili L; Monnin J; Etievant A; Arribas RL; Viejo L; Refouvelet B; Soukup O; Janockova J; Hepnarova V; Korabecny J; Kucera T; Jun D; Andrys R; Musilek K; Baguet A; García-Frutos EM; De Simone A; Andrisano V; Bartolini M; de Los Ríos C; Marco-Contelles J; Haffen E
ACS Chem Neurosci; 2021 Apr; 12(8):1328-1342. PubMed ID: 33797877
[TBL] [Abstract][Full Text] [Related]
25. Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism-In Vitro Study.
Ľupták M; Fišar Z; Hroudová J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430306
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
27. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria.
Nag M
Indian J Exp Biol; 2004 Sep; 42(9):941-4. PubMed ID: 15462192
[TBL] [Abstract][Full Text] [Related]
28. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
[TBL] [Abstract][Full Text] [Related]
29. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
30. In vitro effects of antipsychotics on mitochondrial respiration.
Cikánková T; Fišar Z; Bakhouche Y; Ľupták M; Hroudová J
Naunyn Schmiedebergs Arch Pharmacol; 2019 Oct; 392(10):1209-1223. PubMed ID: 31104106
[TBL] [Abstract][Full Text] [Related]
31. Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease.
Campora M; Canale C; Gatta E; Tasso B; Laurini E; Relini A; Pricl S; Catto M; Tonelli M
ACS Chem Neurosci; 2021 Feb; 12(3):447-461. PubMed ID: 33428389
[TBL] [Abstract][Full Text] [Related]
32. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
34. Inhibition by Zn(2+) of A-form monoamine oxidase in monkey brain mitochondria.
Egashira T; Takayama F; Sakai K
J Pharmacol Sci; 2003 Mar; 91(3):239-45. PubMed ID: 12686747
[TBL] [Abstract][Full Text] [Related]
35. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984
[TBL] [Abstract][Full Text] [Related]
36. Modulation of MAO activity by imidazoline and guanidine derivatives.
Raasch W; Muhle H; Dominiak P
Ann N Y Acad Sci; 1999 Jun; 881():313-31. PubMed ID: 10415932
[TBL] [Abstract][Full Text] [Related]
37. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
Youdim MB; Gross A; Finberg JP
Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases.
Gluck MR; Zeevalk GD
J Neurochem; 2004 Nov; 91(4):788-95. PubMed ID: 15525332
[TBL] [Abstract][Full Text] [Related]
39. An investigation of the monoamine oxidase inhibition properties of pyrrolo[3,4-f]indole-5,7-dione and indole-5,6-dicarbonitrile derivatives.
Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Engelbrecht I; Petzer JP; Yu Suponitsky K; Veselovsky AV
Drug Dev Res; 2018 Mar; 79(2):81-93. PubMed ID: 29570223
[TBL] [Abstract][Full Text] [Related]
40. N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors.
Pozdnev VF; Kirkel AZ; Kamyshanskaya NS; Axenova LN; Medvedev AE
J Neural Transm Suppl; 1998; 52():351-5. PubMed ID: 9564638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
